Susquehanna Fundamental Investments’s Milestone Pharmaceuticals MIST Stock Holding History

Susquehanna Fundamental Investments’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,499	Closed	-$106K	–	1371
2022 Q3	$106K	Buy	+11,499	New	+$87.2K	﹤0.01%	1326
2022 Q1	$153K	Sell	23,854 -7,988	-25%	-$49.9K	﹤0.01%	1409
2021 Q4	$209K	Sell	31,842 -7,960	-20%	-$47.7K	0.01%	1235
2021 Q3	$227K	Sell	39,802 -11,700	-23%	-$66K	﹤0.01%	1498
2021 Q2	$283K	Sell	51,502 -9,135	-15%	-$51.8K	0.01%	1389
2021 Q1	$351K	Sell	60,637 -17,658	-23%	-$129K	0.01%	1257
2020 Q4	$525K	Sell	78,295 -6,860	-8%	-$45.9K	0.01%	1082
2020 Q3	$623K	Buy	85,155 +45,255	+113%	+$324K	0.02%	802
2020 Q2	$151K	Buy	+39,900	New	+$129K	0.01%	868

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna Fundamental Investments's MIST Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Milestone Pharmaceuticals (MIST) in Q4 2022, closing a stake of 11,499 shares — an estimated $106K sold.

Susquehanna Fundamental Investments first reported a position in MIST in Q2 2020 and held it in 9 quarters. The position peaked at $623K in Q3 2020. 56 funds tracked by Wall St. Rank hold MIST as of Q4 2022.

Susquehanna Fundamental Investments reported no remaining Milestone Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Susquehanna Fundamental Investments sold 11,499 Milestone Pharmaceuticals shares in Q4 2022, an estimated $106K.
Susquehanna Fundamental Investments first reported a position in Milestone Pharmaceuticals in Q2 2020 and held it in 9 quarters.
Susquehanna Fundamental Investments's Milestone Pharmaceuticals position peaked at $623K in Q3 2020.
56 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.